Cipher Pharma (CPHR) Tops Q4 EPS by 8c

Cipher Pharma (NASDAQ: CPHR) reported Q4 EPS of $0.08, $0.08 better than the analyst estimate of $0.00. Revenue for the quarter came in at $9.7 million versus the consensus estimate of $9.31 million.

For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance